- Our Doctors
- Dr Gemma Eminowicz
Dr Gemma Eminowicz
MBChB, MRCP, FRCR, MD(Res), Consultant Clinical Oncologist
Languages spoken
English
Expert in
Gynaecological cancers
Overview
Centres
Specialises in
Treatments
Dr Eminowicz is a Consultant Clinical Oncologist and Brachytherapy Lead at University College London hospital (UCLH) and Honorary Clinical Associate Professor at University College London (UCL). Her expertise is complex targeted radiotherapy delivery using image guidance and adaptive techniques as well as systemic therapy for endometrial, cervical and vulvovaginal cancers. She also delivers a broad range of brachytherapy, including gynaecological, oesophageal, bronchus, and paediatric.
After completion of clinical oncology training in 2014 she undertook a MD(Res) at UCL, during which she worked on the INTERLACE trial Radiotherapy Quality Assurance and investigating methods of optimizing radiotherapy delivery for cervical cancer. She is a member of the ESTRO gynae focus group, an active member of GEC-ESTRO, organizer of ESTRO Gyn-SMART webinars and was involved in the GCIG Endometrial cancer consensus conference. Her work has continued to date on multiple phase 3 trials in the treatment of gynaecological cancers.
Career positions
- University College London Hospitals NHS Foundation Trust
Professional memberships
- ESTRO - European Society for Radiotherapy and Oncology
- ESGO - European Society of Gynaecological Oncology
- ESMO - European Society for Medical Oncology
- BGCS - British Gynaecological Cancer Society
- IGCS - International Gynecologic Cancer Society
Qualifications
- MBChB, MRCP, FRCR, MD(Res)
Awards
- BAGP Naveen Singh Research Award 2024
Expertise and interests
- Complex radiotherapy delivery in gynaecological cancer including brachytherapy
Publications
1: Creutzberg C, Kim JW, Eminowicz G et al. The Gynecologic Cancer InterGroup (GCIG) consensus recommendations for clinical research in Endometrial Cancer. Lancet oncology September 2024.
2. Sarwar A, Eminowicz G. Radiotherapy induced ureteric stenosis in locally advanced cervical cancer: A review of current evidence. Brachytherapy, 2024,ISSN 1538-4721, https://doi.org/10.1016/j.brachy.2024.03.002.
3: Mirza MR, RUBY investigators. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer. N Engl J Med. 2023 Jun 8;388(23):2145-2158.
4: Gaze MN, Smeulders N, Ackwerh R, Allen C, Bal N, Boutros M, Cho A, Eminowicz G, Gill E, Fittall MW, Humphries PD, Lim P, Mushtaq I, Nguyen T, Peet C, Pendse D, Polhill S, Rees H, Sands G, Shankar A, Slater O, Sullivan T, Hoskin PJA National Referral Service for Paediatric Brachytherapy: An Evolving Practice and Outcomes Over 13 Years. Clin Oncol (R Coll Radiol). 2022 Dec 30:S0936-6555(22)00609-4. doi: 10.1016/j.clon.2022.12.008. Online ahead of print.
5: Sarwar A, Lalli N, Eminowicz G. Ureter dose optimization during image guided brachytherapy for cervical cancer. Brachytherapy. 2022 Apr 11:S1538-4721(22)00035-6.